Weight Loss Therapeutics Market is Estimated to Advance at a CAGR of 20.6%, reach US$ 20.84 Billion by the end of 2033 | DataM Intelligence

Market Size and Growth:

The Global Weight Loss Therapeutics Market Size reached US$ 3.92 Billion in 2024 and is expected to reach US$ 20.84 Billion by 2033, growing at a CAGR of 20.6% during the forecast period 2025-2033.

The Weight Loss Therapeutics Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Weight Loss Therapeutics market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/weight-loss-therapeutics-market?sz

The Weight Loss Therapeutics Market encompasses pharmaceutical drugs, biologics, and combination therapies designed to aid in weight reduction and obesity management. It includes prescription medications, over-the-counter products, and emerging treatments targeting metabolic regulation, appetite suppression, and fat absorption. The market is driven by rising obesity prevalence, lifestyle changes, and growing demand for effective, safe, and long-term weight management solutions.

Key Developments of USA and Japan:

USA:

Viking Therapeutics' VK2735: Viking Therapeutics announced the launch of a Phase 3 clinical program for its dual GLP-1 and GIP receptor agonist, VK2735. This drug is being developed in both oral and injectable forms. (June 2025)

New Drug Pipeline Announcements: At the 2025 American Diabetes Association meeting, major pharmaceutical companies highlighted their new and next-generation weight-loss drugs. This includes Eli Lilly's oral GLP-1 agonist, orforglipron, which has shown injectable-like efficacy in trials, and Amgen's MariTide, a GIP antagonist with potential for monthly injections. (July 2025)

Japan:

Nxera Pharma's Pipeline Expansion: Nxera Pharma announced a strategic expansion of its proprietary pipeline to focus on obesity and chronic weight management. (August 2025)

Zepbound Approval: Japan's health ministry granted regulatory approval for Eli Lilly's Zepbound (tirzepatide) for obesity treatment, following its previous approval for diabetes. (May 2025)

Key Players:

Novo Nordisk A/S
Currax Pharmaceuticals LLC
Eli Lilly and Company
VIVUS LLC
Rhythm Pharmaceuticals, Inc.
CHEPLAPHARM GmbH
GSK plc
KVK Tech, Inc.
Teva Pharmaceutical Industries Ltd.

Emerging Players:

Ionis Pharmaceuticals
KalVista Pharmaceuticals, Inc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=weight-loss-therapeutics-market

Market Segmentation:

By Therapeutics: Prescription Drugs, Over-the-Counter, Natural Supplements, Others.

By Condition: Obesity, Overweight, Others.

By Dosage Form: Capsules, Tablets, Injectables, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/weight-loss-therapeutics-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Weight Loss Therapeutics market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Weight Loss Therapeutics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Weight Loss Therapeutics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Weight Loss Therapeutics Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Weight Loss Therapeutics Market in 2025?
◆ What is the projected growth rate of the Weight Loss Therapeutics Market through 2033?
◆ Who are the key players in the Weight Loss Therapeutics Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.